About: Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.
Sector: Healthcare
Industry: Diagnostics & Research
Status: deslistada — removed_from_provider. Este ativo não é mais negociado; são exibidos dados históricos.
MYNZ NASDAQ Mainz Biomed BV
Mainz Biomed BV share price
Atividade de preço de MYNZ
Último preço
Variação (24h)
USD
Volume
-
Volume (média 4 sem.)
-
Fechamento anterior
N/D
Último negócio
MYNZ price performance
quote.marketSignals